Cogitars

Cogitars GmbH is dedicated to delivering expert statistical support to pharmaceutical
and biotechnology companies throughout every phase of clinical development, from
early-stage trials to post-market studies. Since its establishment in 2013, the company
has amassed over a decade of in-depth experience, becoming a trusted partner to a wide
range of global clients. With its extensive expertise, Cogitars GmbH has contributed
significantly to the success of countless clinical trials by ensuring the highest standards
of statistical rigor, precision, and compliance. The company takes pride in its
collaborative approach, tailoring its services to meet the unique needs of each client and
project, and helping to bring innovative therapies to patients worldwide.

Cogitars offers expertise in the following areas:

Biostatistical Strategic Consulting: Providing tailored statistical guidance to
optimize clinical trial design, execution, and outcomes

Bayesian Statistics: Leveraging advanced Bayesian methodologies to enhance
decision-making and trial eMiciency

Adaptive Trial Designs: Designing and implementing innovative, flexible trial
structures that allow for modifications based on interim data

Real-Time Data Monitoring: Utilizing their cutting-edge visualization platform,
cogiviz, to enable dynamic and intuitive tracking of trial progress and data insights

Comprehensive Trial Reporting: Delivering detailed and robust trial analyses to
support regulatory submissions and ensure compliance with global standards

Contact

Cogitars GmbH


Poststraße 10
69115 Heidelberg
Germany

Oliver Schönborn-Kellenberger, CEO
Phone  +49 173 6235314
E-Mail info@cogitars.com

Web: https://www.cogitars.com/
LinkedIn: linkedin.com/cogitars